Matthew P. Fox, DSc

Professor, Epidemiology
Matthew Fox
617-358-2062mfox@bu.edu
Crosstown Center – 5522
View full profile at BUMC

Biography

Matthew Fox, DSc, MPH, is a Professor in the Departments of Epidemiology and Global Health at Boston University. Dr. Fox joined Boston University in 2001. His research interests include treatment outcomes in HIV-treatment programs, infectious disease epidemiology (with specific interests in HIV and pneumonia), and epidemiologic methods. Dr. Fox works on ways to improve retention in HIV-care programs in South Africa from the time of testing HIV-positive through long-term treatment. As part of this work, he is involved in analyses to assess the impact of changes in South Africa’s National Treatment Guidelines for HIV. Dr. Fox also does research on quantitative bias analysis and co-authored a book on these methods, Applying Quantitative Bias Analysis to Epidemiologic Data (http://www.springer.com/public+health/book/978-0-387-87960-4). He is also the host of a public health journal club podcast called Free Associations designed to help people stay current in the public health literature and think critically about the quality of research studies (www.pophealthex.org/FA). He currently teaches a third-level epidemiologic methods class, Advanced Epidemiology as well as two other doctoral level epidemiologic methods courses. Dr. Fox is a graduate of the Boston University School of Public Health with a master’s degree in epidemiology and biostatistics and a doctorate in epidemiology.

Other Positions

  • Professor, Global Health, Boston University School of Public Health
  • Center Faculty Member, Center for Global Health & Development , Boston University School of Public Health

Education

  • Boston University School of Public Health, MPH
  • Bates College, BA
  • Boston University School of Public Health, DSc

Classes Taught

  • SPHEP854
  • SPHEP861
  • SPHEP862

Publications

  • Published on 1/1/2019

    Moorhouse M, Maartens G, Venter WDF, Moosa MY, Steegen K, Jamaloodien K, Fox MP, Conradie F. Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes. J Acquir Immune Defic Syndr. 2019 Jan 01; 80(1):73-78. PMID: 30334876.

    Read at: PubMed
  • Published on 1/1/2019

    Hamer DH, Hansoti B, Prabhakaran D, Huffman MD, Nxumalo N, Fox MP, Gopal S, Oberhelman R, Mwananyanda L, Vwalika B, Rispel LC. Global Health Research Mentoring Competencies for Individuals and Institutions in Low- and Middle-Income Countries. Am J Trop Med Hyg. 2019 Jan; 100(1_Suppl):15-19. PMID: 30430976.

    Read at: PubMed
  • Published on 12/28/2018

    Sadruddin S, Khan IUH, Fox MP, Bari A, Khan A, Thea DM, Khan A, Khan I, Ahmad I, Qazi SA. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial. Clin Infect Dis. 2018 Dec 28. PMID: 30596964.

    Read at: PubMed
  • Published on 12/1/2018

    Modest AM, Wise LA, Fox MP, Weuve J, Penzias AS, Hacker MR. IVF success corrected for drop-out: use of inverse probability weighting. Hum Reprod. 2018 12 01; 33(12):2295-2301. PMID: 30325421.

    Read at: PubMed
  • Published on 12/1/2018

    Onoya D, Hirasen K, van den Berg L, Miot J, Long LC, Fox MP. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa. Drug Saf. 2018 12; 41(12):1343-1353. PMID: 30043384.

    Read at: PubMed
  • Published on 11/13/2018

    Chammartin F, Zürcher K, Keiser O, Weigel R, Chu K, Kiragga AN, Ardura-Garcia C, Anderegg N, Laurent C, Cornell M, Tweya H, Haas AD, Rice BD, Geng EH, Fox MP, Hargreaves JR, Egger M. Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis. Clin Infect Dis. 2018 Nov 13; 67(11):1643-1652. PMID: 29889240.

    Read at: PubMed
  • Published on 10/11/2018

    Rosen S, Maskew M, Brennan AT, Fox MP, Vezi L, Ehrenkranz PD, Venter WDF. Improved simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE II): protocol for a randomized evaluation. Trials. 2018 Oct 11; 19(1):548. PMID: 30305142.

    Read at: PubMed
  • Published on 10/3/2018

    Brennan AT, Jamieson L, Crowther NJ, Fox MP, George JA, Berry KM, Stokes A, Maskew M, Sanne I, Long L, Cassim N, Rosen S. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa. PLoS One. 2018; 13(10):e0204020. PMID: 30281618.

    Read at: PubMed
  • Published on 10/3/2018

    Fox MP, Pascoe SJS, Huber AN, Murphy J, Phokojoe M, Gorgens M, Rosen S, Wilson D, Pillay Y, Fraser-Hurt N. Effectiveness of interventions for unstable patients on antiretroviral therapy in South Africa: results of a cluster-randomised evaluation. Trop Med Int Health. 2018 Oct 03. PMID: 30281882.

    Read at: PubMed
  • Published on 10/1/2018

    Hendrickson CJ, Pascoe SJS, Huber AN, Moolla A, Maskew M, Long LC, Fox MP. "My future is bright…I won't die with the cause of AIDS": ten-year patient ART outcomes and experiences in South Africa. J Int AIDS Soc. 2018 Oct; 21(10):e25184. PMID: 30318848.

    Read at: PubMed

View 197 more publications:View full profile at BUMC

News & In the Media